Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDK2 | Q15119 | 2/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.37 |
| ▸ | TP53 | P04637 | 3/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.37 |
| ▸ | CCR1 | P32246 | 2/20 | 0.37 |
| ▸ | CCR5 | P51681 | 2/20 | 0.37 |
| ▸ | CCR8 | P51685 | 2/20 | 0.37 |
| ▸ | LMNA | P02545 | 2/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.37 |
| ▸ | ALPL | P05186 | 1/20 | 0.37 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.37 |
| ▸ | ALPI | P09923 | 1/20 | 0.37 |
| ▸ | ALPG | P10696 | 1/20 | 0.37 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.37 |
| ▸ | HTT | P42858 | 1/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
| ▸ | MAPT | P10636 | 2/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20735869 | 0.96 | PDK2 (0.41) | PDK2KDM4ETP53SMN1; SMN2CCR1 | |
| SCHEMBL20735804 | 0.96 | PDK2 (0.41) | PDK2KDM4ETP53SMN1; SMN2CCR1 | |
| SCHEMBL20735863 | 0.95 | PDK2 (0.39) | PDK2KDM4ETP53SMN1; SMN2CCR1 | |
| SCHEMBL20735864 | 0.92 | PDK2 (0.38) | PDK2KDM4ETP53SMN1; SMN2CCR1 | |
| SCHEMBL20735862 | 0.92 | PDK2 (0.38) | PDK2KDM4ETP53SMN1; SMN2CCR1 | |
| SCHEMBL20735861 | 0.91 | PDK2 (0.37) | PDK2KDM4ETP53SMN1; SMN2CCR1 | |
| SCHEMBL20735872 | 0.87 | PDK2 (0.31) | PDK2KDM4ETP53SMN1; SMN2CCR1 | |
| SCHEMBL20736578 | 0.87 | PDK2 (0.39) | PDK2KDM4ETP53SMN1; SMN2CCR1 | |
| SCHEMBL20736909 | 0.87 | PDK2 (0.37) | PDK2KDM4ETP53SMN1; SMN2CCR1 | |
| SCHEMBL20735880 | 0.86 | KDM4E (0.43) | PDK2KDM4ETP53SMN1; SMN2CCR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12022728-B2 | Organic electroluminescent element and electronic device | IDEMITSU KOSAN CO., LTD. (JP) | 2024-06-25 | — | — | US | disclosed |
| US-12022728-B2 | Organic electroluminescent element and electronic device | IDEMITSU KOSAN CO., LTD. (JP) | 2024-06-25 | — | — | US | disclosed |
| US-11552251-B2 | Organic electroluminescent element and electronic device | IDEMITSU KOSAN CO., LTD. (JP) | 2023-01-10 | — | — | US | disclosed |
| US-20190051835-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2019-02-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11552251-B2 | Organic electroluminescent element and electronic device | L1CAM, ESR1, LEF1 | PDK2 2420/4885KDM4E 2169/4885TP53 3684/4885 |
| US-20190051835-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE | L1CAM, ESR1, LEF1 | PDK2 2420/4885KDM4E 2169/4885TP53 3684/4885 |
| US-12022728-B2 | Organic electroluminescent element and electronic device | L1CAM, ESR1, LEF1 | PDK2 2420/4885KDM4E 2169/4885TP53 3684/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.